Illumina
ILMN
$1.37 (1.80%)
1D
1W
3M
1Y
5Y
ALL
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
GlobeNewsWire • 6 days ago • ILMN
Target Validation for Genetic Targets Innovation Research Report 2025: 14,172 Deals Totaling $11.4 Billion - BGI biotech and illumina are Among the Leaders with Strong PortfoliosPRNewsWire • 9 days ago • ILMN
Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovationPRNewsWire • 14 days ago • ILMN
Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025Zacks Investment Research • 20 days ago • ILMN
Here's Why Illumina (ILMN) is a Strong Value StockCNBC • 26 days ago • ILMN
Corvex's Meister joins the board at Illumina. Here's how he can create value for shareholdersCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.